Biden Officials Stave Off Sticker Shock on Medicare Drug Premiums

Health
By Rebecca Robbins and Reed Abelson from NYT Health https://ift.tt/fvlFPjS
via IFTTT Health Insurance and Managed Care, Medicare, United States Politics and Government, Drugs (Pharmaceuticals), Presidential Election of 2024, Prices (Fares, Fees and Rates), Inflation Reduction Act of 2022, Medicare Advantage Federal regulators spent billions of dollars to avoid a spike in costs for older Americans that could have been politically damaging to the presidential campaign of Vice President Kamala Harris.

Comments

Popular posts from this blog

F.D.A. Poised to Restrict Access to Covid Vaccines

U.S. Will No Longer Recommend Covid Shots for Children and Pregnant Women